You are here: HOME
Society News & Announcements
Temperature Matters
Partners and Sponsors

Our Mission Statement

The Society for Thermal Medicine is a 501(c)(3), non-profit organization whose mission is to significantly improve patient treatment outcomes by advancing the science, development and application of Thermal Therapy.

Our Society strives to:

  • Promote new discovery in thermal biology, physics/engineering, and medicine.
  • Sponsor high quality forums for education of medical professionals in the practice of thermal medicine.
  • Advocate for increased patient access to appropriate, high quality, thermal therapies.

Get to Know Us

Founded in 1986, STM is a premier, international scientific forum for fostering interaction and innovation in the study of biological, physical and medical applications of thermal therapy for cancer and other diseases and for facilitating a greater basic understanding of the role of temperature in cellular and molecular function. A key goal of the Society is to facilitate rapid dissemination of exciting scientific breakthroughs in thermal medicine in order to expedite the translation of both basic and applied research to the clinic for the immediate benefit of patients.

The Society meets annually in the United States, (and with other international societies every 4th year) for members to exchange new research information in the areas of thermal physics/engineering, and biology and medicine, with sub-specialty interests including thermal physiology , immunology, regulation of gene/protein expression, nanoparticles and drug delivery, inflammation and metabolism, hypoxia, vascular function and the tumor microenvironment, radiation and chemotherapy sensitization by heat, thermal ablation, chemistry, and new industry development . A major emphasis at the annual meetings is placed on presentations of new translational and clinical data in thermal therapy. There are many opportunities for new investigators to present their data, and graduate students, laboratory and clinical fellows, and allied health professionals are particularly welcome at our meetings; several career development and mentor-ship opportunities are available.

Among other activities, the Society sponsors CME accredited educational events, its own outstanding journal: The International Journal of Hyperthermia, a website for scientific and informational exchange, and yearly travel awards and speaking opportunities for new investigators.

What is Thermal Medicine?

Thermal Medicine, or the manipulation of body or tissue temperature for the treatment of disease, can be traced back to the earliest practice of medicine. Cultures from around the world can point to ancient uses of hot and cold therapy for specific medical applications, including cancer. Modern research in thermal medicine aims to understand molecular, cellular and physiological effects of temperature manipulation and the “stress” response, as well as to develop effective and safe equipment for clinical application and temperature monitoring. As a result, today there are a growing number of clinical applications of thermal therapy that benefit patients with a variety of diseases. More ... 

STM 2014: Join Us in Minneapolis

Meeting Registrations

Invited Speakers
ABSTRACT SUBMISSIONS:   Presenting authors can still edit abstracts via the submission website. https://stm.conference-services.net/authorlogin.asp?conferenceID=3805&language=en-uk

New Investigator travel Award Submissions:

New Investigator Travel Award abstract submissions are currently under review. The review committee hopes to announce winners the week of February 10.

Phase III Clinical Study: Pancreatic Cancer

The Society of Thermal Medicine (STM) highlighted initiation of an important Phase III clinical study, hyperthermia in combination with chemotherapy for the treatment of pancreatic cancer patients, during its 29th Annual Conference, which was held in Portland, OR.  The randomized, multicenter, Phase III study, the Hyperthermia European Adjuvant Trial (HEAT), sponsored by the Munich Groshadern University Medical School (UMS) and the European Society for Hyperthermic Oncology, compares hyperthermia with chemotherapy (gemcitabine plus cisplatin) to chemotherapy (gemcitabine) alone. Patients are randomized following standard surgical resection of the tumor. The study is open for enrollment of 350 patients and has already enrolled the first three patients. More....

30th Annual Meeting A Success

The Westin Resort & Casino provided a wonderful back drop for the 30th Annual Meeting of the Society for Thermal Medicine. Congratulations to Dieter Haemmerich and members of the Program Committee for hosting such a nice Annual Meeting in Aruba.

Many Annual Meeting attendees managed to combine scientific sessions with tourism and  recreational activities while in Aruba.

STM Members Elizabeth Graham, Allison Thompson, and Chris MacNeill took advantage of a lunch break to explore Aruba.

STM Image Archive Added to the Member Center

Using the images provided by Dennis Leeper, Chair of the History Committee, we have added a STM slideshow image archive to the Member Center.


The Member Center is restricted to current members via log-in. Unless you’ve changed your password, your log-in data is:

Username: Your E-mail Address on file with STM

Password: Your Last Name - first initial capitalized; if necessary, add nines after your name until there are at least 7 characters

Hint: While online, please verify your membership contact information. Save any edits made. Thank you!


STM Receives NIH Funding

The Society for Thermal Medicine is delighted to announce funding received from the National Institutes of Health (NIH) for the STM Annual Meeting. Beginning this year with our meeting in Aruba and continuing  for a total of 3 years, the STM Annual Meeting will be in part funded by grant R13CA174356 from the National Cancer Institute.


We appreciate support from the National Institutes of Health and that of our sponsors and partners: Insightec, Philips Healthcare, the Focused Ultrasound Surgery Foundation, the Radiation Research Society, Alpinion Medical Systems, BSD Medical Corporation, Oncotherm Hightech Medicine and the International Journal of Hyperthermia.


International Journal of Hyperthermia

the Official Journal of STM

2010 Impact Factor: 2.929
5-Year Impact Factor: 3.419
Frequency: 8 issues per year

Read More: http://informahealthcare.com/hth


IJH Current Issue Table of Contents

Thu, 10 Apr 2014 16:37:50 GMT

Thu, 03 Apr 2014 15:25:37 GMT

Wed, 26 Mar 2014 17:01:32 GMT

Tue, 18 Mar 2014 17:28:29 GMT

Wed, 26 Feb 2014 14:31:22 GMT

Wed, 26 Feb 2014 14:31:15 GMT

Wed, 26 Feb 2014 14:31:05 GMT

Wed, 26 Feb 2014 14:30:49 GMT

Wed, 26 Feb 2014 14:30:25 GMT

Wed, 26 Feb 2014 14:29:59 GMT

Wed, 26 Feb 2014 14:29:52 GMT

Wed, 26 Feb 2014 14:29:15 GMT

Wed, 26 Feb 2014 14:28:51 GMT

Wed, 26 Feb 2014 14:28:40 GMT

Wed, 26 Feb 2014 14:28:27 GMT

Mon, 03 Feb 2014 15:33:04 GMT


© 2013 Society for Thermal Medicine
Contact Us: STM@allenpress.com
Tel: 1-785-865-9403 (or toll-free in USA 1-800-627-0326)
Fax: 1-785-843-6153 

eBusiness assistance provided by Allen Press, Inc.